Ratings by Wolfe Research (Kalpit Patel)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/2/2026 | Ascendis Pharma | ASND | Maintain | Outperform (N/A) |
|
Details | ||
| 1/12/2026 | Soleno Therapeutics Inc. | SLNO | Maintain | Outperform (N/A) |
|
Details | ||
| 12/31/2025 | Corcept Therapeutics | CORT | Downgrade | Underperform (Peerperform) |
70.19 (33.87) |
-51.75% | Details | |
| 11/18/2025 | Summit Therapeutics plc | SMMT | New Coverage | Peerperform (N/A) |
18.03 (15.11) |
-16.2% | Details | |
| 11/18/2025 | Tango Therapeutics Inc. | TNGX | New Coverage | Peerperform (N/A) |
8.17 (16.95) |
107.47% | Details | |
| 11/18/2025 | Scholar Rock | SRRK | New Coverage | Outperform (N/A) |
37.41 (45.29) |
21.06% | Details | |
| 11/18/2025 | Janux Therapeutics | JANX | New Coverage | Peerperform (N/A) |
29.28 (13.84) |
-52.73% | Details | |
| 11/18/2025 | Revolution | RVMD | New Coverage | Outperform (N/A) |
67.75 (98.40) |
45.24% | Details | |
| 11/18/2025 | Soleno Therapeutics Inc. | SLNO | New Coverage | Outperform (N/A) |
49.42 (39.68) |
-19.71% | Details | |
| 11/18/2025 | Exelixis | EXEL | New Coverage | Peerperform (N/A) |
41.65 (41.55) |
-0.24% | Details | |
| 11/18/2025 | ORIC Pharmaceuticals | ORIC | New Coverage | Peerperform (N/A) |
12.25 (13.71) |
11.92% | Details | |
| 11/18/2025 | Arcellx Inc. | ACLX | New Coverage | Peerperform (N/A) |
89.98 (114.33) |
27.06% | Details | |
| 11/18/2025 | Ascendis Pharma | ASND | New Coverage | Outperform (N/A) |
204.40 (240.65) |
17.73% | Details | |
| 11/18/2025 | Corcept Therapeutics | CORT | New Coverage | Peerperform (N/A) |
75.54 (70.19) |
-7.08% | Details | |
| 11/18/2025 | Celcuity Inc | CELC | New Coverage | Outperform (N/A) |
92.68 (115.00) |
24.08% | Details |
